Inhaled budesonide for the treatment of acute wheezing and dyspnea in children up to 24 months old receiving intravenous hydrocortisone

Inhaled budesonide for the treatment of acute wheezing and dyspnea in children up to 24 months old receiving intravenous hydrocortisone

Autor Sano, F. Google Scholar
Cortez, G. K. Google Scholar
Solé, Dirceu Autor UNIFESP Google Scholar
Naspitz, Charles Kirov Autor UNIFESP Google Scholar
Instituição Universidade Federal de São Paulo (UNIFESP)
Resumo Background: Inhaled corticosteroids are highly effective in the treatment of asthma at all ages, and their use in younger children is increasing. There are no data currently available on the treatment of infants with acute wheeze and dyspnea with nebulized budesonide.Objective: Our purpose was to assess the clinical effect of nebulized budesonide in infants with acute wheeze and dyspnea.Methods: A prospective study was performed comparing the addition of nebulized budesonide 0.25 mg every 6 hours (group A, n = 32) and nebulized ipratropium bromide 0.1 mg every 6 hours (group B, n = 39) with the normal treatment regimen with intravenous fluid, hydrocortisone, and nebulized fenoterol. A clinical score was made at admission and every 12 hours. the score included wheezing and costal retraction (0-6) and respiratory rate (counts per minute).Results: Seventy-one infants aged 3 to 24 months were studied (42 boys). A statistically significant reduction was seen in clinical score and respiratory rate in both groups 12 hours after admission. the children who received budesonide improved significantly faster than the children who received ipratropium bromide, and the hospitalization period was significantly lower in the budesonide group (66.4 hours) compared with the ipratropium bromide group (93 hours) (P <.01). Three patients from the budesonide group and 2 from the ipratropium bromide group were readmitted within the first 4 weeks.Conclusion: Treatment of infants with acute wheeze with nebulized budesonide is associated with faster clinical improvement and reduction in hospital stay period.
Palavra-chave asthma
budesonide
inhaled steroids
efficacy
infants
Idioma Inglês
Data de publicação 2000-04-01
Publicado em Journal of Allergy and Clinical Immunology. St Louis: Mosby-year Book Inc, v. 105, n. 4, p. 699-703, 2000.
ISSN 0091-6749 (Sherpa/Romeo, fator de impacto)
Publicador Mosby-year Book Inc
Extensão 699-703
Fonte http://dx.doi.org/10.1067/mai.2000.104784
Direito de acesso Acesso aberto Open Access
Tipo Artigo
Web of Science WOS:000086604100006
Endereço permanente http://repositorio.unifesp.br/handle/11600/26276

Exibir registro completo




Arquivo

Arquivo Tamanho Formato Visualização

Não existem arquivos associados a este item.

Este item está nas seguintes coleções

Buscar


Navegar

Minha conta